Supernus Pharmaceuticals
SUPN
#4335
Rank
โ‚น265.49 B
Marketcap
โ‚น4,574
Share price
1.35%
Change (1 day)
70.33%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: โ‚น265.49 Billion

As of July 2026 Supernus Pharmaceuticals has a market cap of โ‚น265.49 Billion. This makes Supernus Pharmaceuticals the world's 4335th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น265.49 B0.02%
2025โ‚น265.44 B50.72%
2024โ‚น176.12 B33.81%
2023โ‚น131.62 B-17.51%
2022โ‚น159.56 B38.24%
2021โ‚น115.42 B18.65%
2020โ‚น97.28 B9.48%
2019โ‚น88.85 B-26.88%
2018โ‚น121.52 B-6.83%
2017โ‚น130.43 B53.45%
2016โ‚น85.00 B94.21%
2015โ‚น43.76 B93.61%
2014โ‚น22.60 B21.37%
2013โ‚น18.62 B54.93%
2012โ‚น12.02 B

End of Day market cap according to different sources

On Jul 4th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

โ‚น265.49 Billion
by Nasdaq info icon info icon
โ‚น265.49 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น60.280 T 22,604.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น15.819 T 5,858.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น103.053 T 38,715.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น11.300 T 4,156.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
โ‚น142.81 B-46.21%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
โ‚น2.246 T 746.12%๐Ÿ‡บ๐Ÿ‡ธ USA